Vitamin D Deficiency and Hair Loss: A Publishing Surgeon’s Clinical Case, the VDR Science Competitors Miss, and the 40–100 ng/mL Target That Changes Everything
Introduction: When a Single Blood Test Changes Everything
Approximately one billion people worldwide are vitamin D deficient. Yet most hair loss evaluations never include a vitamin D panel. This disconnect represents one of the most significant blind spots in modern hair restoration medicine.
Generic wellness content typically states that “vitamin D may help hair loss.” The real story, however, is far more specific, more nuanced, and more actionable. The connection between vitamin D deficiency and hair loss extends beyond simple association into the realm of receptor biology, precise serum targets, and documented clinical outcomes.
Dr. Sharon Keene, a publishing hair restoration surgeon and former President of the International Society of Hair Restoration Surgery (ISHRS), addressed this gap directly in her 2022 peer-reviewed case report published in Hair Transplant Forum International. The case documented a real patient with a serum 25(OH)D level of just 12 ng/mL who experienced measurable frontal hair regrowth on vitamin D3 supplementation alone.
This article goes beyond the association to explain the vitamin D receptor (VDR) science that competitors miss, the correct target range of 40 to 100 ng/mL, and the critical safety blind spot that almost no consumer content addresses: hypervitaminosis D as a paradoxical cause of hair loss.
Dr. Keene’s credentials distinguish her perspective from content aggregators who simply cite other people’s research. As a Platinum Follicle Award recipient and ISHRS Past President, she brings decades of clinical and research experience to this topic. By the end of this article, readers will understand whether their hair loss could be vitamin D related, what testing to request, what a clinically appropriate target looks like, and when professional evaluation is warranted.
Vitamin D Is Not Just a Vitamin: Understanding the Hormone Behind Hair Health
The first fundamental misconception to clarify is that vitamin D is technically a steroid hormone, not merely a dietary vitamin. This distinction matters profoundly for understanding its role in hair health.
The synthesis pathway begins when UV-B light triggers production in the skin. The liver then converts this to 25(OH)D, and the kidneys subsequently convert it to the active form, 1,25-(OH)2D3, also known as calcitriol.
As a steroid hormone, vitamin D influences gene expression across virtually every tissue in the body, including hair follicles. Its broad roles encompass immune modulation, anti-inflammatory activity, calcium metabolism, and cardiovascular and neurologic function. All of these have downstream relevance to hair follicle health.
For supplementation purposes, vitamin D3 (cholecalciferol) is the preferred form over D2 (ergocalciferol) because it raises blood levels more effectively and remains active longer in the body.
The mechanism through which vitamin D exerts its effects is the vitamin D receptor, or VDR. Understanding this receptor is essential to grasping why vitamin D deficiency impacts hair so significantly.
The VDR: The True Regulator of Hair Cycling That Competitors Miss
The vitamin D receptor is expressed in key hair follicle structures: the outer root sheath, hair matrix, and dermal papilla. This expression pattern places VDR at the center of hair biology.
Hair cycles through three phases: anagen (growth), catagen (regression), and telogen (shedding). VDR is critical for initiating the anagen phase after follicle morphogenesis. Research published in Life Science Alliance (2023) demonstrated that in VDR-knockout mice, the hair cycle is halted during the catagen stage, preceding alopecia. This establishes VDR as an essential regulator of hair follicle regression and cycling.
The most important nuance that competitor content consistently misses is this: VDR’s role in hair cycling is largely ligand-independent. This means the receptor itself, not just vitamin D levels, is critical for proper hair cycling. Foundational research from 2005 in Molecular Endocrinology established that mutations in the VDR cause alopecia by preventing anagen initiation, even when vitamin D blood levels are normal.
The clinical implication is significant. Serum testing alone does not tell the complete story. Even patients with normal vitamin D levels may have VDR-related hair cycling issues. Optimizing vitamin D levels is one lever in the system, but it is not the only lever.
How Vitamin D Deficiency Affects Different Types of Hair Loss
The landmark 2024 systematic review and meta-analysis published in Frontiers in Nutrition provides the largest evidence base assembled on this topic, covering 81 studies and 15,339 alopecia patients.
The prevalence data by alopecia type helps readers self-identify their risk:
- Alopecia areata (AA): 51.94% of patients had vitamin D deficiency
- Female pattern hair loss (FPHL): 50.38% of patients had vitamin D deficiency
- Male androgenetic alopecia (MAGA): 47.38% of patients had vitamin D deficiency
- Telogen effluvium (TE): 53.51% of patients had vitamin D deficiency
The odds ratio for AA patients is particularly striking. AA patients are nearly three times more likely to be vitamin D deficient compared to controls, with an odds ratio of 2.84 (95% CI: 1.89 to 4.26).
A 2024 Pakistani cohort study found that 79.17% of 120 diffuse hair fall patients were vitamin D3 deficient, with a mean serum level of just 17.33 ng/mL. This illustrates how prevalent this deficiency is across diverse populations.
Alopecia Areata and Vitamin D: The Autoimmune Connection
Alopecia areata involves the immune system mistakenly targeting hair follicles, disrupting the normal growth cycle. Vitamin D’s immunomodulatory role is directly relevant here. Active vitamin D helps regulate T-cell activity and suppress inflammatory cytokines, both of which are implicated in AA pathology.
The nearly three times higher odds of vitamin D deficiency in AA patients represents one of the strongest associations in the alopecia-vitamin D literature. While vitamin D optimization is a meaningful adjunct for AA patients, it is not a standalone cure. Professional evaluation and treatment planning remain essential.
Androgenetic Alopecia and Vitamin D: The DHT Interaction
Androgenetic alopecia (AGA) is primarily driven by DHT-induced follicle miniaturization and represents the most common form of hair loss in both men and women. A 2024 study published in ScienceDirect confirmed that 1,25-(OH)2D3 promotes hair regeneration, prolongs the anagen phase, enhances dermal papilla cell proliferation, and can counteract the inhibitory effects of DHT on hair growth via NLRP3/IL-1β and HIF-1α/IL-1β signaling pathways.
AGA patients who are vitamin D deficient often also have lower levels of zinc, copper, magnesium, selenium, and vitamin B12. This suggests a broader nutritional deficiency pattern that warrants comprehensive evaluation.
Addressing vitamin D deficiency in AGA patients is not a replacement for established treatments such as finasteride, minoxidil, or hair transplantation. However, it may be an important adjunct that is frequently overlooked.
Dr. Sharon Keene’s 2022 Case Report: Real Evidence From a Publishing Surgeon
Dr. Keene’s credentials establish why her clinical observations carry unique authority. As ISHRS Past President (2014 to 2015), Platinum Follicle Award recipient (2013), and peer-reviewed publishing surgeon, she brings a level of expertise that distinguishes her work from generic health content.
Her case report published in Hair Transplant Forum International (July/August 2022, Vol. 32, Issue 4), documented a patient with severe vitamin D deficiency (serum 25(OH)D of 12 ng/mL) and advanced androgenetic alopecia. The patient experienced significant frontal hair regrowth after vitamin D3 supplementation alone, without finasteride or topical minoxidil.
This case is clinically significant because it is not a population study or animal model. It is a documented, peer-reviewed human case with photographic evidence. The American Hair Loss Association has cited this study as “pivotal” evidence linking low vitamin D levels with increased hair shedding and poor follicular health.
Dr. Keene now routinely advises all patients to check for and treat vitamin D deficiency alongside any other recommended hair loss therapies. In her practice, she observes vitamin D deficiency in at least 30% of her patients, despite practicing in sunny Arizona where sun exposure is abundant.
As an integral team member at Hair Transplant Specialists, Dr. Keene brings this research-backed clinical approach to every patient evaluation.
The Safety Blind Spot: When Too Much Vitamin D Causes Hair Loss
The same nutrient that contributes to hair loss when deficient can also cause hair loss when taken in excess. This critical safety angle is almost entirely absent from competitor content.
Hypervitaminosis D occurs because vitamin D is fat-soluble and accumulates in body tissues. Excessive supplementation (typically from very high-dose supplements, not sun exposure) can elevate serum calcium and cause systemic toxicity.
Dr. Keene specifically documented a case of possible telogen effluvium caused by hypervitaminosis D. This is not a theoretical risk; it is a clinically observed outcome. Elevated calcium levels from vitamin D toxicity can disrupt normal physiological processes, potentially triggering diffuse hair shedding.
This is precisely why baseline blood testing must precede supplementation. Empiric high-dose vitamin D supplementation without knowing baseline levels is not safe. Most wellness articles recommend vitamin D for hair loss without any mention of this risk, potentially encouraging readers to self-supplement at high doses without medical supervision.
Dr. Keene’s protocol requires periodic blood sampling to guard against hypervitaminosis D, not just to confirm adequacy.
The Target Range That Changes Everything: Why 600 IU/Day Is Not Enough
Standard reference points define vitamin D deficiency as serum 25(OH)D below 20 ng/mL and insufficiency as 20 to 30 ng/mL. The NIH RDA is 600 IU per day for adults.
However, the NIH RDA is insufficient for deficient patients. This population-level minimum is designed to prevent rickets and bone disease, not to serve as a therapeutic dose for patients with documented deficiency.
Dr. Keene’s hair-specific clinical target is oral vitamin D3 supplementation to achieve and maintain serum 25(OH)D levels between 40 and 100 ng/mL, with periodic monitoring. The ISHRS official summary of her research endorses this target range.
The clinical rationale is straightforward. The 40 to 100 ng/mL range reflects the level at which vitamin D’s immunomodulatory, anti-inflammatory, and VDR-activating effects are optimally expressed. This is not merely the threshold to avoid deficiency.
Most competitor articles cite the generic NIH RDA of 600 IU per day without acknowledging that a patient with a serum level of 12 ng/mL requires a very different therapeutic approach. The appropriate supplementation dose varies significantly by individual baseline level, body weight, absorption capacity, and other factors. Physician-guided testing and dosing is essential rather than relying on generic supplement recommendations.
Who Is at Risk: Identifying Vitamin D Deficiency in Hair Loss Patients
Vitamin D deficiency affects approximately one billion people globally, according to StatPearls. This is not a niche problem.
Primary risk factors for vitamin D deficiency relevant to hair loss patients include:
- Limited sun exposure (indoor lifestyle, northern latitudes, winter months)
- Consistent sunscreen use
- Darker skin pigmentation (reduced UV-B absorption)
- Obesity (fat-soluble vitamin sequestration)
- Malabsorption conditions (Crohn’s disease, celiac disease, bariatric surgery)
- Aging (reduced skin synthesis efficiency)
- Certain medications
The counterintuitive finding from Dr. Keene’s practice bears noting: at least 30% of her patients in sunny Arizona are vitamin D deficient. Geography alone does not protect against deficiency.
A comprehensive hair loss blood panel should include serum 25(OH)D, ferritin, thyroid panel (TSH, free T3, free T4), zinc, and B12. The 25(OH)D serum test is the correct test for assessing vitamin D status, not the active form (1,25-(OH)2D3), which can appear normal even when stores are depleted.
The Clinical Protocol: Test First, Then Treat
Dr. Keene’s clinical protocol is straightforward: baseline blood testing must precede supplementation.
The clinical decision framework is as follows:
- If serum 25(OH)D is below 20 ng/mL (deficient): therapeutic supplementation is indicated
- If 20 to 30 ng/mL (insufficient): supplementation is appropriate
- If already above 40 ng/mL: high-dose supplementation is not warranted and could be harmful
Vitamin D3 (cholecalciferol) is preferred over D2 (ergocalciferol) because it is more effective at raising blood levels and has longer-lasting activity.
The monitoring protocol involves periodic re-testing, typically every three to six months during active supplementation, to confirm that levels are rising appropriately and to guard against hypervitaminosis D.
Vitamin D supplementation should be considered an adjunct to, not a replacement for, a comprehensive hair loss treatment plan that may include other medical, surgical, or non-surgical interventions.
Conclusion: The Vitamin D Deficiency and Hair Loss Connection Is Deeper Than Most Realize
Vitamin D is a steroid hormone with direct roles in hair follicle cycling. The VDR, not just vitamin D levels, is the critical regulator. Deficiency affects roughly half of all alopecia patients across major hair loss types. The correct therapeutic target of 40 to 100 ng/mL is far above the NIH minimum.
Excess vitamin D can also cause hair loss, making physician-guided testing and monitoring non-negotiable.
Dr. Keene’s case report anchors this article’s authority: a real patient, a documented outcome, published in a peer-reviewed journal by a surgeon with decades of clinical and research experience.
Vitamin D deficiency screening belongs in every hair loss evaluation, alongside ferritin, thyroid, and other nutritional markers. It is not a standalone solution but a potentially significant and frequently missed contributor.
As the science of hair follicle biology continues to evolve, the VDR’s role will likely become an even more important target for both diagnostic evaluation and therapeutic intervention. Understanding the science is the first step. Personalized evaluation by a qualified specialist is what translates knowledge into results.
Ready to Find Out If Vitamin D Deficiency Is Contributing to Your Hair Loss?
For those experiencing hair loss who have never had vitamin D levels tested, that single blood test could be a meaningful piece of the diagnostic picture.
Hair Transplant Specialists, with Dr. Sharon Keene as an integral team member, offers the rare combination of published research expertise and comprehensive clinical evaluation for hair loss patients. A consultation includes a thorough evaluation of potential contributing factors (including nutritional deficiencies), a review of appropriate testing, and a personalized treatment plan that may include vitamin D optimization alongside surgical or non-surgical hair restoration options.
The practice is located at 2121 Cliff Dr. Suite 210, Eagan, MN 55122. Contact the office at (651) 393-5399 or visit INeedMoreHair.com. Office hours are Monday through Thursday 9 AM to 5 PM, Friday 9 AM to 3 PM, and Saturday and Sunday by appointment.
Scheduling a consultation provides access to a physician-guided evaluation: personalized clinical assessment from a team with over 100 combined years of hair restoration experience, not generic supplement advice.
Hair loss is complex, but the right evaluation can reveal treatable contributors that many patients never knew to look for.
